Herbal Analytics Signs Two-year Service Agreement with MediGrow

Affinor Growers Inc. (CSE:AFI,OTCQB:RSSFF) announced that Herbal Analytics, a testing laboratory in Washington State, has signed an exclusive service agreement with MediGrow. Affinor holds a 49-percent stake in Herbal Analytics.

As quoted in the press release:

MediGrow (www.medigrowproducts.com) is in the final approval stages with the Washington State Liquor Control Board (LCB) for a I-502 licence, necessary for marijuana production. MediGrow will operate in a 10,000 square foot commercial building on 35 acres in Arlington, Washington, with abilities to increase grow capacity to 30,000 square foot in 2016 using greenhouse grow technology. MediGrow, Herbal Analytics and Affinor have combined resources to explore grow methods best used for compound research, clinical trials and product formulations for drug discovery.

Herbal Analytics will provide the following services to MediGrow in accordance with the terms and conditions of the signed agreement beginning April 1st, 2015 until March 31st, 2017:

  • Drug discovery research and growing method consulting;
  • Quality assurance testing upon LCB approval;
  • Bi-weekly condition testing of planted material;
  • As needed testing for future crop selection;
  • As needed consulting services on data;
  • As needed courier service and onsite planning.

Affinor Chairman Nick Brusatore commented:

We are very pleased with this constant cashflow agreement and we are continuing negotiations for further contracts in that sector.

Click here to read the full Affinor Growers Inc. (CSE:AFI,OTCQB:RSSFF) press release.